Kohjin Bio KBM551 (IL-2 Depleted Culture medium for human T cell activation and expansion)
Kohjin Bio KBM551 (IL-2 Depleted Culture medium for human T cell activation and expansion)
KBM551 is a medium suitable for both activated and expanded cultures of human peripheral blood T cells stimulated with solid-phase anti-CD3 antibody
Add to cart
KBM 551 is a specialized cell culture medium designed to support the activation and expansion of human peripheral blood T cells.
This versatile medium provides an optimal environment for T-cell proliferation.
Kohjin Bio KBM551 (IL-2 Depleted Culture medium for human T cell activation and expansion) is a RUO product.
Key Features:
- T cell-specific: Tailored for the culture of activated and expanded T cells.
- IL-2-free: Requires the addition of exogenous IL-2 for optimal growth.
- Enhanced buffering: Maintains stable pH for optimal cell culture conditions.
- Antibiotic-free: Can be supplemented with desired antibiotics as needed.
Recommended Applications:
- T cell research: Studying T cell function and activation.
- Immunotherapy: Developing T cell-based therapies for various diseases.
Reference Publications
Nishi, K., Ishikura, S., Umebayashi, M., Morisaki, T., Inozume, T., Kinugasa, T., Aoki, M., Nimura, S., Swain, A., Yoshida, Y., Hasegawa, S., Nabeshima, K., Sakata, T., Shirasawa, S., & Tsunoda, T.
Mutant KRAS promotes NKG2D+ T cell infiltration and CD155 dependent immune evasion.
Anticancer Research, 40(8), 4663–4674. (2020).
Article Snippet: “Generation of cytokine-activated killer cells. PBMCs were activated in KBM551 medium (Kohjin Bio, Saitama, Japan) supplemented with 5% human serum, 2000 U/ml penicillin, 10 μg/ml streptomycin, 2000 U/ml recombinant human interleukin-2 (IL-2), and 0.5% albumin (Nihon Pharmaceutical Co., Ltd., Tokyo, Japan) in T-75 flasks coated with 2 μg/ml anti-CD3 monoclonal antibody (OKT3, Janssen Pharmaceutical K.K., Tokyo, Japan).”
Kim, A., Lee, KG., Kwon, Y. et al.
Off-the-Shelf, Immune-Compatible Human Embryonic Stem Cells Generated Via CRISPR-Mediated Genome Editing.
Stem Cell Rev and Rep 17, 1053–1067 (2021).
DOI: https://doi.org/10.1007/s12015-020-10113-7
Article Snippet: “To expand activated T cells, PBMCs were added to flasks pre-coated with anti-CD3 (1:500, Clone OKT-3, Invitrogen) and anti-CD28 (1:500, Clone CD28.2, Invitrogen) monoclonal antibodies and then incubated in serum-free KBM551 medium (Kohjin Bio) containing 200 IU/ml human recombinant interleukin-2 (rhIL-2) (R&D Systems) at 37 °C in a 5% CO2 atmosphere.”
Related Products
HOW CAN WE HELP YOU? Our specialists are to help you find the best product for your application. We will be happy to help you find the right product for the job.
TALK TO A SPECIALIST
Contact our Customer Care, Sales & Scientific Assistance
EMAIL US
Consult and asked questions about our products & services
DOCUMENTATION
Documentation of Technical & Safety Data Sheet, Guides and more..
NEWSLETTER
We gladly support you by keeping you updated on our latest products and the developments around our services.
ATLANTIS BIOSCIENCE PTE LTD
362 Upper Paya Lebar Rd, #07-15,
Singapore 534963
WeChat ID: +65 8608 0974
© 2015-2023 Atlantis Bioscience Pte Ltd. All rights reserved. Co Reg No: 201539516N